Letter from the Editor

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Imagining what’s next…

By 2020, it’s estimated that 1.7 megabytes of data will be created every second for every person on earth; 90% of the world’s data has been created in the last two years; healthcare data is doubling every 18 months; 5 billion people around the world lack access to surgeons; 50% of preclinical studies can’t be reproduced; a trillion sensors are currently in use … the numbers are staggering. And yet, human labor is finite. These are some of the statistics that led us to take a different approach to this year’s special Year in Preview issue. We posed 20 aspirational questions to our community of thought leaders with the goal to curate their thinking about 20 trends — from molecule to market and beyond — that are at the forefront of conversations taking place across the industry every day.

As the leading strategic futurist Nancy Giordano asks: “how do you build a path forward for something that is happening in real time?” This is the challenge that healthcare leaders across the spectrum face every day. Not only must you be prepared to manage technology that is constantly evolving, information and data creation that continues to increase at rates unprecedented in human existence, and cultural shifts that are creating vast opportunities as well as illuminating vast gaps, you need to be thinking exponentially to adopt to a future state that moves from sick care to health care.

The future is both fantastic in terms of what’s possible to impact billions of people in the next decade and a bit frightening for all of the same reasons. The industry will struggle with a multitude of ethical challenges, including science being pushed beyond current boundaries, cybersecurity, and data ownership. But most experts believe the pros of exponential medical advancements outweigh the cons.

We will continue to see start-up companies shatter the status quo as well as nonhealthcare companies disrupt the market in innovative ways.

In putting together the responses from more than 140 thought leaders to our 20 aspirational questions, it became apparent that there were definite overlaps between the different topics, highlighting the need for better and more collaborative thinking. It’s near impossible to have a silo-mindset in today’s life-sciences ecosystem and expect to be successful in the future. It’s evident that the future lies in bringing together the strength of diverse talent pools and new ways of thinking to solve some of the biggest healthcare challenges facing us today and in the future.

As we close out 2019, we want to thank those willing to face the what ifs of tomorrow for this special issue as well as all of you — readers, thought leaders, advertisers, and community members — who continue to share our journey of exploring the topics and trends that impact the life-sciences industry.

Taren Grom, Editor

~~~~~~~~~~~~~~~~~~~~~~~~~

Their word…

Denise Myshko
Managing Editor

The industry is developing and advancing preventive and life-saving gene therapies and personalized medicines; success depends on how well stakeholders’ needs are met.

Robin Robinson
Senior Editor

From behavioral science to data science, the industry is finding new ways to innovate in the ever-evolving digitalized world.

Kim Ribbink
Features Editor

In an industry replete with innovative thinkers and people committed to saving lives, the “what ifs” posed in this issue will no doubt quickly become reality.

~~~~~~~~~~~~~~~~~~~~~~~~~

January 2020

Small Pharma Innovation
Medical Storytelling
Antisense and RNAi Therapies
Data Ownership
Biotech CEOs
Showcase: Virtual Health
Showcase: High-Science Brands

~~~~~~~~~~~~~~~~~~~~~~~~~

Masthead

The forum for the industry executive

 

Volume 19 • Number 10
Publisher Lisa Banket
Editor Taren Grom
Creative Director Marah Walsh

Managing Editor
Denise Myshko

Senior Editor
Robin Robinson

Features Editor
Kim Ribbink

Design Associate
Ariel Medel

Director of Sales
Cathy Tracy

National Account Manager
Suzanne Besse

Webcast Network Producer
Daniel Limbach

Circulation Assistant
Kathy Deiuliis

Copyright 2019
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Nineteen, Number Ten

PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by ­Pharma­­Linx LLC, P.O. Box 327, Titusville, NJ 08560. ­Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.

Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: tgrom@pharmavoice.com.

Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: mwalsh@pharmavoice.com.

Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.

Advertising in PharmaVoice: To advertise in Pharma­­Voice please contact our Advertising ­Department at P.O. Box 327, Titusville, NJ 08560, or ­telephone us at 609.730.0196. E-mail: lbanket@pharmavoice.com.

Letters …
Send your letters to feedback@pharma­voice.com. Please include your name, title, company, and business phone number. Letters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC.

 

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK